|
|
|
Insider
Information: |
Auerbach Mark |
Relationship: |
Director |
City: |
Spring Valley |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
1,864,435 |
|
Indirect Shares
|
1,885,956 |
|
|
Direct
Value |
$142 |
|
|
Indirect Value
|
$33 |
|
|
Total
Shares |
3,750,391 |
|
|
Total
Value |
$174 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Par Pharmaceutical Companies Inc |
PRX |
Executive Chairman, Di... |
2006-01-09 |
35,730 |
2004-05-06 |
0 |
Premium* |
|
Neuro-Hitech Pharmaceuticals Inc |
NHPI |
Director |
2008-06-24 |
300,000 |
2008-06-24 |
602,623 |
Premium* |
|
Rxelite Inc |
RXEI |
Director |
2008-06-04 |
1,416,666 |
2007-07-13 |
316,666 |
Premium* |
|
Optimer Pharmaceuticals Inc |
OPTR |
Director |
2013-10-24 |
0 |
2007-09-12 |
0 |
Premium* |
|
Collexis Holdings Inc |
CLXS |
Director |
|
0 |
2008-07-07 |
966,667 |
Premium* |
|
RCS Capital Corp |
RCAP |
Director |
2015-12-18 |
112,039 |
2014-06-05 |
0 |
Premium* |
|
Pardes Biosciences Ord Shs |
PRDS |
Director |
2023-08-31 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
29 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
29 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|